Mirati Therapeutics, Inc.
Overview
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company that develops targeted therapies to treat cancer. The company focuses on genetic and epigenetic drivers of cancer and leverages precision medicine strategies to address the unmet medical needs of cancer patients.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Mirati Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.